Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Sinbobon Jun 11, 2012 11:36am
189 Views
Post# 19999486

RE: RE: RE: RE: RE: RE: NEWS! BTI RNS

RE: RE: RE: RE: RE: RE: NEWS! BTI RNS

Yes Risky...it is amazing scientific news! And as you said, the scientific/pharma industry will be taking extreme interest in today's updare, particularly this part: " The data showed that 6.6% of the injected dose of BT2111 penetrated the Blood-Brain Barrier and entered brain tissue. This is consistent with previous studies showing that Transcend can effectively deliver several types of different compounds to the brain. Remarkably, the rate of BT2111uptake into the brain was 1000-fold greater than Herceptin® on its own."

What's not to understand for even the newcomers? Looks like the flippers are working the stock over early here and maybe trying to get in lower...who knows. Well under 100,000 shares traded so far. News has yet to hit the wires and media. The typical 'sell on news' traders today either don't care or don't understand even minutely what the significance of the news is from a scientific perspective. BUT, once disseminated, you can bet the house that those in the pharma community will..and serious deliberations are under way. Their risk of ommission would be just too great here. This is globally impactful.

So, where does that leave Shire? They have surely had the same results and must now make a decision. I wonder what kind of licensing offer they will make? .... $100 million? $500 million?The dollar projections even at this early stage are gob smacking...and more importantly think of the world changing impact on the human scale! As Rob Hutchison said in the video(https://www.b-tv.com/features/watch-now.html?clip=biOasisTechnologiesMay12.wmv)...at least 50 major pharmas can apply Bioasis Transcend technology to their various compunds. That is truly gargantuan!

Seems to me this is one of the biggest pharmaceutical breakthroughs in history assuming (and the 20 year evidence supports it) this natural human protein ( not an engineerd one) works to carry drugs across the BBB in humans. The question now is, why wouldn't it? It would appear that the big pharmas cannot afford to gamble that it is anything but a breakthrough. Just my opinion.

Bullboard Posts